Table 2.
Pulmonary Function In Hispanic and Non-Hispanic White Patients With CF
Hispanic Patients |
Non-Hispanic White Patients |
Difference | 95% CI | p-value | |
---|---|---|---|---|---|
FVC | 87.6% | 93.0% | −5.3% | −6.2% to −4.5% | <0.001 |
FEV1 | 79.9% | 85.6% | −5.8% | −6.7% to −4.8% | <0.001 |
FEV1 Between Patient Change | −1.02% | −1.25% | 0.23% | −0.00% to 0.46% | 0.05 |
FEV1 Within Patient Change | −0.03% | −0.02% | −0.01% | −0.06% to 0.04% | 0.6 |
FEF25–75 | 67.3% | 71.0% | −3.8% | −5.4% to −2.2% | <0.001 |
FEV1/FVC | 0.806 | 0.812 | −0.006 | −0.01 to −0.002 | 0.004 |
1,375 patients did not have FEF25–75% data. 445 patients did not have FEV1 decline data.
Models adjusted for age, sex, PERT, BMI, sweat chloride concentration, MRSA, Pseudomonas aeruginosa, maternal education level, insurance type, tobacco exposure, age at diagnosis, CF-related diabetes, CFTR mutation class, and location.
All values shown are percent predicted except FEV1/FVC